Page values for "Trastuzumab"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 862,288 |
| _pageName | Page | Trastuzumab |
| _pageTitle | String | Trastuzumab |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | Trastuzumab |
| Short_definition | String | Trastuzumab - (pronounced) (tras-TOO-zoo-mab) drug used alone or with other drugs to treat certain types of breast, stomach, and gastroesophageal junction cancer that are HER2 positive. It is also being studied in the treatment of other types of cancer. |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |